Income Statement Sino-Agri Leading Biosciences Co.,Ltd

Stocks

603970

CNE100002TN4

Agricultural Chemicals

End-of-day quote Shanghai S.E. Other stock markets 2026-07-21			5-day change	1st Jan Change
9.850 ^CNY	-1.99%		-1.40%	-23.41%

04-26	Sino-Agri Leading Biosciences Co.,Ltd announces Annual dividend, payable on June 12, 2026	CI
04-24	Sino-Agri Leading Biosciences Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

3468bfb6302db91efc08920b171be3.XcL8l-bzyOwn1L6hHmQsniBSXYTHLgyNGOJR4zUTWpk.aa3N-qu2rK1xlu7Gdg146GE4NcnqWF7ic7IJkXB6Y_wYtLj2rqaqjVSz-w

Published financial data: SINO-AGRI LEADING BIOSCIENCES CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	8.82B	11.7B	10.46B	10.6B	11.24B
Total Revenues	8.82B	11.7B	10.46B	10.6B	11.24B
Cost of Goods Sold, Total	8.29B	10.97B	9.76B	9.88B	10.52B
Gross Profit	530M	727M	702M	718M	724M
Selling General & Admin Expenses, Total	249M	295M	320M	322M	327M
Provision for Bad Debts	-1.61M	2.54M	27.88M	17.87M	51.89M
R&D Expenses	37.53M	45.79M	65.36M	66.74M	65.33M
Other Operating Expenses	10.58M	9.38M	6.88M	38.38K	7.68M
Other Operating Expenses, Total	295M	352M	420M	407M	452M
Operating Income	235M	374M	281M	312M	273M
Interest Expense, Total	-33.84M	-26.76M	-15.63M	-22.44M	-22.97M
Interest And Investment Income	66.55M	28.65M	39.66M	18.45M	6.83M
Net Interest Expenses	32.71M	1.9M	24.02M	-3.99M	-16.15M
Currency Exchange Gains (Loss)	13.87M	-15.19M	-16.22M	-34.32K	-28.19M
Other Non Operating Income (Expenses)	-8.24M	-29.78M	1.12M	-11.3M	-16.66M
EBT, Excl. Unusual Items	273M	331M	290M	296M	212M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-13.55M	-18.55M	11.83M	1.26M	20.18M
Gain (Loss) On Sale Of Assets	296K	-765K	708K	-578K	-414K
Asset Writedown	-27.19M	293K	-244K	-19.71K	-1.24M
Insurance Settlements	-	-	-	-	-
Other Unusual Items	7.35M	13.42M	12.62M	5.01M	8.97M
EBT, Incl. Unusual Items	240M	326M	315M	302M	239M
Income Tax Expense	54.6M	77.78M	67.55M	73.23M	53.3M
Earnings From Continuing Operations	186M	248M	248M	229M	186M
Net Income to Company	186M	248M	248M	229M	186M
Minority Interest	-15.33M	-37.58M	-22.74M	-25.5M	-13.59M
Net Income - (IS)	170M	210M	225M	203M	173M
Net Income to Common Incl Extra Items	170M	210M	225M	203M	173M
Net Income to Common Excl. Extra Items	170M	210M	225M	203M	173M
Per Share Items
Net EPS - Basic	0.63	0.78	0.84	0.76	0.64
Basic EPS - Continuing Operations	0.63	0.78	0.84	0.76	0.64
Basic Weighted Average Shares Outstanding	269M	269M	269M	269M	269M
Net EPS - Diluted	0.63	0.78	0.84	0.76	0.64
Diluted EPS - Continuing Operations	0.63	0.78	0.84	0.76	0.64
Diluted Weighted Average Shares Outstanding	269M	269M	269M	269M	269M
Normalized Basic EPS	0.58	0.63	0.59	0.59	0.44
Normalized Diluted EPS	0.58	0.63	0.59	0.59	0.44
Dividend Per Share	0.25	0.39	0.45	0.45	0.32
Payout Ratio	55.61	44.83	54.9	71.31	82.94
Supplemental Items
EBITDA	245M	387M	292M	322M	282M
EBITA	240M	378M	282M	312M	273M
EBIT	235M	374M	281M	312M	273M
EBITDAR	250M	389M	311M	342M	301M
Total Revenues (As Reported)	8.82B	11.7B	10.46B	10.6B	11.24B
Effective Tax Rate - (Ratio)	22.73	23.88	21.44	24.24	22.26
Total Current Taxes	61.51M	91.31M	75.24M	68.39M	52.78M
Total Deferred Taxes	-6.91M	-13.53M	-7.69M	4.84M	515K
Normalized Net Income	156M	169M	159M	160M	119M
Non-Cash Pension Expense	279K	55.67K	67.66K	-	-
Supplemental Operating Expense Items
Advertising Expense	25.83M	40.44M	48.03M	55.36M	70.21M
Selling and Marketing Expenses	181M	224M	244M	242M	254M
General and Administrative Expenses	65.37M	70.28M	74.75M	79.35M	71.53M
Research And Development Expense From Footnotes	37.98M	46.24M	65.36M	66.74M	65.33M
Net Rental Expense, Total	4.4M	1.57M	19.3M	19.97M	18.37M
Imputed Operating Lease Interest Expense	1.14M	360K	2.91M	5.16M	5.57M
Imputed Operating Lease Depreciation	3.25M	1.21M	16.39M	14.81M	12.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	967M	1.93B	864M	405M	250M
Short Term Investments	-	-	-	-	5.53M
Trading Asset Securities, Total	507M	1B	792M	1B	864M
Total Cash And Short Term Investments	1.47B	2.93B	1.66B	1.41B	1.12B
Accounts Receivable, Total	199M	321M	1.71B	1.69B	1.51B
Other Receivables	37.94M	116M	59.03M	49.42M	27.51M
Total Receivables	237M	437M	1.77B	1.74B	1.54B
Inventory	1.72B	1.56B	1.54B	1.57B	1.47B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	1.08B	1.05B	779M	634M	519M
Total Current Assets	4.5B	5.98B	5.74B	5.35B	4.65B
Gross Property Plant And Equipment	141M	143M	150M	149M	151M
Accumulated Depreciation	-67.21M	-82.92M	-78.57M	-90.08M	-102M
Net Property Plant And Equipment	73.77M	60.39M	71.84M	58.53M	48.06M
Long-term Investments	86.17M	113M	99.13M	95.09M	167M
Goodwill	-	-	-	-	-
Other Intangibles, Total	50.53M	5.14M	4.29M	3.65M	3.08M
Deferred Tax Assets Long-Term	25.3M	42.44M	50.38M	43.95M	42.46M
Deferred Charges Long-Term	1.69M	1.48M	2.53M	5.67M	3.21M
Other Long-Term Assets, Total	-	42M	42M	42M	-
Total Assets	4.74B	6.24B	6.01B	5.6B	4.91B
Liabilities
Accounts Payable, Total	1.3B	2.65B	2.76B	2.12B	1.48B
Accrued Expenses, Total	40.48M	75.32M	81.12M	83.75M	88.2M
Short-term Borrowings	942M	801M	629M	628M	558M
Current Portion of Long-Term Debt	-	85.56K	100M	-	-
Current Portion of Leases	9.71M	3.5M	10.05M	8.73M	3.67M
Current Income Taxes Payable	24.68M	55.09M	30.86M	25.19M	26.28M
Unearned Revenue Current, Total	893M	932M	624M	898M	918M
Other Current Liabilities	221M	117M	153M	140M	80.32M
Total Current Liabilities	3.43B	4.63B	4.39B	3.9B	3.15B
Long-Term Debt	-	100M	-	-	-
Long-Term Leases	5.46M	5.61M	9.29M	4.32M	9.29M
Unearned Revenue Non Current	8.39M	-	326K	146K	1.62M
Deferred Tax Liability Non Current	12.11M	15.72M	12.58M	9.74M	15.49M
Other Non Current Liabilities	5.59M	6.01M	4.28M	4.28M	4.46M
Total Liabilities	3.46B	4.76B	4.41B	3.92B	3.18B
Common Stock, Total	192M	192M	269M	269M	269M
Additional Paid In Capital	298M	302M	238M	238M	238M
Retained Earnings	648M	791M	910M	993M	1.04B
Comprehensive Income and Other	33M	32.93M	22.2M	20.69M	24.7M
Total Common Equity	1.17B	1.32B	1.44B	1.52B	1.58B
Minority Interest	110M	166M	155M	162M	152M
Total Equity	1.28B	1.48B	1.59B	1.68B	1.73B
Total Liabilities And Equity	4.74B	6.24B	6.01B	5.6B	4.91B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	269M	269M	269M	269M	269M
ECS Total Common Shares Outstanding	269M	269M	269M	269M	269M
Book Value / Share	4.36	4.9	5.36	5.66	5.86
Tangible Book Value	1.12B	1.31B	1.44B	1.52B	1.57B
Tangible Book Value Per Share	4.17	4.89	5.34	5.64	5.85
Total Debt	957M	910M	748M	642M	571M
Net Debt	-517M	-2.02B	-908M	-764M	-549M
Debt Equivalent Oper. Leases	35.18M	12.57M	154M	160M	147M
Minority Interest, Total (Incl. Fin. Div)	110M	166M	155M	162M	152M
Equity Method Investments, Total	2.17M	29.28M	29.6M	30.57M	31.28M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	44.43M	37.64M	45.89M	48.96M	60.25M
Inventories - Work In Process, Total	2.35M	1.66M	4.58M	3.94M	7.01M
Inventories - Finished Goods, Total	1.7B	1.57B	1.57B	1.59B	1.44B
Inventories - Others	4.51M	3.28M	2.41M	3.45M	5.78M
Buildings, Total	17.54M	17.54M	17.54M	28.31M	28.31M
Machinery, Total	98.37M	96.06M	89.14M	87.7M	84.72M
Full Time Employees	855	861	855	817	736
Accumulated Allowance for Doubtful Accounts (Supple)	42.59M	44.13M	71.97M	89.32M	125M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	170M	210M	225M	203M	173M
Depreciation & Amortization - CF	14.62M	20.16M	20.83M	20.29M	20.14M
Amortization of Goodwill and Intangible Assets - (CF)	4.78M	3.24M	1.21M	419K	144K
Depreciation & Amortization, Total	19.39M	23.4M	22.05M	20.71M	20.28M
Amortization of Deferred Charges, Total - (CF)	767K	731K	617K	2.85M	3.07M
(Gain) Loss From Sale Of Asset	-296K	765K	-708K	578K	356K
(Gain) Loss on Sale of Investments - (CF)	-45.29M	9.06M	-36.52M	-9.91M	-22.29M
Asset Writedown & Restructuring Costs	27.19M	-293K	244K	19.71K	1.23M
Provision and Write-off of Bad Debts	-1.61M	2.54M	27.88M	17.87M	51.89M
Other Operating Activities, Total	67.53M	138M	112M	73.12M	58.32M
Change In Accounts Receivable	300M	-184M	-1.08B	473M	235M
Change In Inventories	-484M	135M	-8.8M	-16.67M	122M
Change In Accounts Payable	267M	1.21B	-194M	-463M	-721M
Change In Deferred Taxes	3.78M	-13.53M	-7.69M	4.81M	651K
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	325M	1.54B	-944M	307M	-78.31M
Capital Expenditure	-3.99M	-3.44M	-4.37M	-2.18M	-1.37M
Sale of Property, Plant, and Equipment	1.15M	385K	20.07M	116K	508K
Cash Acquisitions	-	-	-	-	-
Divestitures	86.23M	-	-	4.5M	-116K
Investment in Marketable and Equity Securities, Total	-38.01M	-573M	210M	-210M	139M
Other Investing Activities, Total	32.64M	9.12M	24.35M	8.05M	5.07M
Cash from Investing	78.02M	-567M	250M	-200M	143M
Short Term Debt Issued, Total	1.58B	-	-	1.2B	1.75B
Long-Term Debt Issued, Total	-	1.2B	1.43B	-	-
Total Debt Issued	1.58B	1.2B	1.43B	1.2B	1.75B
Short Term Debt Repaid, Total	-1.76B	-	-	-1.3B	-1.82B
Long-Term Debt Repaid, Total	-10.55M	-1.25B	-1.61B	-11.43M	-11.92M
Total Debt Repaid	-1.77B	-1.25B	-1.61B	-1.31B	-1.83B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-94.71M	-94.3M	-123M	-145M	-143M
Common & Preferred Stock Dividends Paid	-94.71M	-94.3M	-123M	-145M	-143M
Other Financing Activities, Total	-25.41M	23.4M	-21.6M	-14.09M	-15.35M
Cash from Financing	-313M	-123M	-328M	-271M	-237M
Foreign Exchange Rate Adjustments	8.31M	-89.78M	-15.31M	-582K	-8.91M
Net Change in Cash	98.54M	756M	-1.04B	-164M	-181M
Supplemental Items
Cash Income Tax Paid (Refund)	-68.5M	-189M	-18.24M	11.04M	5.08M
Levered Free Cash Flow	178M	1.57B	-1.03B	-48.83M	-75.13M
Unlevered Free Cash Flow	199M	1.59B	-1.02B	-34.81M	-60.77M
Change In Net Working Capital	-36.16M	-1.33B	1.21B	251M	253M
Net Debt Issued / Repaid	-193M	-52.38M	-183M	-112M	-78.17M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.35	4.26	2.87	3.36	3.24
Return on Total Capital	6.52	10.1	7.42	8.35	7.38
Return On Equity %	15.31	17.93	16.08	13.97	10.91
Return on Common Equity	15.51	16.9	16.31	13.74	11.14
Margin Analysis
Gross Profit Margin %	6.01	6.21	6.71	6.78	6.44
SG&A Margin	2.82	2.52	3.06	3.04	2.91
EBITDA Margin %	2.78	3.31	2.79	3.04	2.51
EBITA Margin %	2.72	3.23	2.7	2.95	2.43
EBIT Margin %	2.66	3.2	2.69	2.94	2.43
Income From Continuing Operations Margin %	2.1	2.12	2.37	2.16	1.66
Net Income Margin %	1.93	1.8	2.15	1.92	1.53
Net Avail. For Common Margin %	1.93	1.8	2.15	1.92	1.53
Normalized Net Income Margin	1.76	1.45	1.52	1.51	1.06
Levered Free Cash Flow Margin	2.02	13.43	-9.84	-0.46	-0.67
Unlevered Free Cash Flow Margin	2.26	13.57	-9.74	-0.33	-0.54
Asset Turnover
Asset Turnover	2.01	2.13	1.71	1.83	2.14
Fixed Assets Turnover	152.33	174.4	158.19	162.55	210.92
Receivables Turnover (Average Receivables)	21.44	44.98	10.31	6.23	7.02
Inventory Turnover (Average Inventory)	5.62	6.69	6.3	6.35	6.91
Short Term Liquidity
Current Ratio	1.31	1.29	1.31	1.37	1.47
Quick Ratio	0.5	0.73	0.78	0.81	0.84
Operating Cash Flow to Current Liabilities	0.09	0.33	-0.22	0.08	-0.02
Days Sales Outstanding (Average Receivables)	17.02	8.12	35.39	58.71	52.01
Days Outstanding Inventory (Average Inventory)	64.97	54.53	57.95	57.6	52.81
Average Days Payable Outstanding	47.06	66.57	101.42	90.01	63.01
Cash Conversion Cycle (Average Days)	34.93	-3.92	-8.07	26.3	41.81
Long Term Solvency
Total Debt/Equity	74.73	61.29	46.94	38.13	33.04
Total Debt / Total Capital	42.77	38	31.94	27.6	24.83
LT Debt/Equity	0.43	7.11	0.58	0.26	0.54
Long-Term Debt / Total Capital	0.24	4.41	0.4	0.19	0.4
Total Liabilities / Total Assets	72.99	76.22	73.47	69.96	64.81
EBIT / Interest Expense	6.94	13.99	17.99	13.89	11.88
EBITDA / Interest Expense	7.52	14.87	19.4	14.81	12.76
(EBITDA - Capex) / Interest Expense	7.4	14.74	19.12	14.72	12.7
Total Debt / EBITDA	3.76	2.29	2.47	1.93	1.95
Net Debt / EBITDA	-2.03	-5.08	-2.99	-2.3	-1.87
Total Debt / (EBITDA - Capex)	3.82	2.31	2.5	1.94	1.96
Net Debt / (EBITDA - Capex)	-2.06	-5.13	-3.04	-2.31	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.84	32.61	-10.59	1.3	6.09
Gross Profit, 1 Yr. Growth %	2.88	37.04	-3.48	2.38	0.86
EBITDA, 1 Yr. Growth %	-1.36	57.89	-24.52	10.16	-12.43
EBITA, 1 Yr. Growth %	-1.92	57.49	-25.19	10.51	-12.67
EBIT, 1 Yr. Growth %	-1.56	59.31	-24.87	10.84	-12.46
Earnings From Cont. Operations, 1 Yr. Growth %	19.73	33.55	-0.12	-7.55	-18.68
Net Income, 1 Yr. Growth %	28.59	23.5	6.91	-9.55	-15.17
Normalized Net Income, 1 Yr. Growth %	61.97	9.17	-6.4	0.71	-25.61
Diluted EPS Before Extra, 1 Yr. Growth %	28.6	23.5	6.91	-9.55	-15.16
Accounts Receivable, 1 Yr. Growth %	-68.04	61.04	432.07	-0.93	-10.63
Inventory, 1 Yr. Growth %	38.76	-8.9	-1.73	2.43	-6.58
Net Property, Plant and Equip., 1 Yr. Growth %	75.37	-18.13	18.96	-18.54	-17.88
Total Assets, 1 Yr. Growth %	17.84	31.68	-3.81	-6.76	-12.33
Tangible Book Value, 1 Yr. Growth %	23.7	17.19	9.31	5.68	3.7
Common Equity, 1 Yr. Growth %	14.23	12.57	9.21	5.62	3.66
Cash From Operations, 1 Yr. Growth %	-7.58	371.89	-161.49	-132.56	-125.47
Capital Expenditures, 1 Yr. Growth %	-73.38	-13.75	26.92	-49.99	-37.31
Levered Free Cash Flow, 1 Yr. Growth %	-63	782.33	-165.5	-95.26	53.85
Unlevered Free Cash Flow, 1 Yr. Growth %	-60.88	697.03	-164.2	-96.58	74.6
Dividend Per Share, 1 Yr. Growth %	16.66	57.16	14.53	0	-28.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	42.53	32.73	8.89	-4.83	3.67
Gross Profit, 2 Yr. CAGR %	9.61	18.74	15.01	-0.59	1.62
EBITDA, 2 Yr. CAGR %	12.29	24.79	9.17	-8.81	-1.71
EBITA, 2 Yr. CAGR %	13.15	24.28	8.55	-9.08	-1.69
EBIT, 2 Yr. CAGR %	13.91	25.23	9.41	-8.74	-1.5
Earnings From Cont. Operations, 2 Yr. CAGR %	22.11	26.45	15.48	-3.91	-13.3
Net Income, 2 Yr. CAGR %	19.69	26.02	14.9	-1.66	-12.4
Normalized Net Income, 2 Yr. CAGR %	34.54	32.87	1.09	-2.91	-13.44
Diluted EPS Before Extra, 2 Yr. CAGR %	19.7	26.02	14.9	-1.66	-12.4
Accounts Receivable, 2 Yr. CAGR %	-10.39	-28.26	192.72	129.6	-5.9
Inventory, 2 Yr. CAGR %	17.67	12.43	-5.38	0.33	-2.18
Net Property, Plant and Equip., 2 Yr. CAGR %	44.49	19.82	-1.31	-1.56	-18.21
Total Assets, 2 Yr. CAGR %	31.56	24.57	12.57	-5.3	-9.59
Tangible Book Value, 2 Yr. CAGR %	16.01	20.4	13.17	7.48	4.69
Common Equity, 2 Yr. CAGR %	10.68	13.39	10.87	7.4	4.63
Cash From Operations, 2 Yr. CAGR %	21.93	108.83	70.34	-55.26	-71.2
Capital Expenditures, 2 Yr. CAGR %	22.22	-52.08	4.62	-20.33	-44.01
Levered Free Cash Flow, 2 Yr. CAGR %	8.81	80.69	140.41	-82.37	-72.99
Unlevered Free Cash Flow, 2 Yr. CAGR %	5.51	76.57	126.2	-85.19	-75.58
Dividend Per Share, 2 Yr. CAGR %	18.31	35.4	34.16	7.02	-15.67
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.18	39.15	16.35	6.3	-1.32
Gross Profit, 3 Yr. CAGR %	9	18.08	10.82	10.64	-0.11
EBITDA, 3 Yr. CAGR %	11.24	25.8	5.54	9.5	-9.99
EBITA, 3 Yr. CAGR %	13.36	26.33	4.94	9.2	-10.24
EBIT, 3 Yr. CAGR %	14.43	27.39	5.62	9.88	-10
Earnings From Cont. Operations, 3 Yr. CAGR %	17.26	25.81	16.88	7.23	-9.11
Net Income, 3 Yr. CAGR %	13.83	20.95	19.29	6.09	-6.39
Normalized Net Income, 3 Yr. CAGR %	18.34	25.42	18.22	0.96	-11.16
Diluted EPS Before Extra, 3 Yr. CAGR %	13.83	20.95	19.3	6.09	-6.38
Accounts Receivable, 3 Yr. CAGR %	-9.51	8.94	39.9	103.99	67.64
Inventory, 3 Yr. CAGR %	14.53	8.05	7.5	-2.85	-2.03
Net Property, Plant and Equip., 3 Yr. CAGR %	22.51	19.56	19.53	-7.42	-7.33
Total Assets, 3 Yr. CAGR %	22.41	31.6	14.3	5.72	-7.7
Tangible Book Value, 3 Yr. CAGR %	15.05	16.4	16.58	10.62	6.21
Common Equity, 3 Yr. CAGR %	10.62	11.3	11.98	9.09	6.14
Cash From Operations, 3 Yr. CAGR %	70.47	91.43	38.93	-1.88	-62.92
Capital Expenditures, 3 Yr. CAGR %	-23.71	8.81	-33.7	-18.2	-26.45
Levered Free Cash Flow, 3 Yr. CAGR %	50.4	118.6	28.84	-35.03	-63.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	66.97	107.02	26.02	-44.09	-66.3
Dividend Per Share, 3 Yr. CAGR %	18.88	30.06	28.06	21.64	-6.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.02	27.27	22.87	19.53	11.1
Gross Profit, 5 Yr. CAGR %	5.82	12.21	11.37	10.23	7.04
EBITDA, 5 Yr. CAGR %	10.94	19.21	10.41	10.61	2.58
EBITA, 5 Yr. CAGR %	12.9	21.69	11.41	10.76	2.24
EBIT, 5 Yr. CAGR %	12.98	22.77	12.4	11.48	2.71
Earnings From Cont. Operations, 5 Yr. CAGR %	17.1	22.55	16.54	12.95	3.72
Net Income, 5 Yr. CAGR %	15.82	18.42	14.26	11.34	5.43
Normalized Net Income, 5 Yr. CAGR %	20.65	21.32	11.08	13.21	4.36
Diluted EPS Before Extra, 5 Yr. CAGR %	9.34	12.41	14.26	11.34	5.43
Accounts Receivable, 5 Yr. CAGR %	-10.63	6.53	44.72	46.79	19.38
Inventory, 5 Yr. CAGR %	5.11	4.67	6.1	4.89	3.52
Net Property, Plant and Equip., 5 Yr. CAGR %	2.54	3.64	12.36	10.62	2.7
Total Assets, 5 Yr. CAGR %	12.93	17.54	18.38	15.38	4.07
Tangible Book Value, 5 Yr. CAGR %	33.36	15.25	14.3	12.74	11.67
Common Equity, 5 Yr. CAGR %	27.69	10.98	10.72	9.72	8.98
Cash From Operations, 5 Yr. CAGR %	16.41	24.24	70.42	7.03	-25.97
Capital Expenditures, 5 Yr. CAGR %	-35.89	-42.63	-13.44	-3.95	-38.03
Levered Free Cash Flow, 5 Yr. CAGR %	24.85	31.61	81.44	-20.14	-31.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.13	30.76	88.53	-27.92	-34.63
Dividend Per Share, 5 Yr. CAGR %	-	25.94	24.77	20.3	8.35